Polatuzumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Polatuzumab, covering 2025-12-31 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL). [Phase 2]